225 related articles for article (PubMed ID: 23440245)
1. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.
Santoro F; Botrugno OA; Dal Zuffo R; Pallavicini I; Matthews GM; Cluse L; Barozzi I; Senese S; Fornasari L; Moretti S; Altucci L; Pelicci PG; Chiocca S; Johnstone RW; Minucci S
Blood; 2013 Apr; 121(17):3459-68. PubMed ID: 23440245
[TBL] [Abstract][Full Text] [Related]
2. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function.
Heideman MR; Wilting RH; Yanover E; Velds A; de Jong J; Kerkhoven RM; Jacobs H; Wessels LF; Dannenberg JH
Blood; 2013 Mar; 121(11):2038-50. PubMed ID: 23327920
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
4. HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis.
Zimberlin CD; Lancini C; Sno R; Rosekrans SL; McLean CM; Vlaming H; van den Brink GR; Bots M; Medema JP; Dannenberg JH
FASEB J; 2015 May; 29(5):2070-80. PubMed ID: 25648995
[TBL] [Abstract][Full Text] [Related]
5. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
[TBL] [Abstract][Full Text] [Related]
6. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
7. Redundant control of adipogenesis by histone deacetylases 1 and 2.
Haberland M; Carrer M; Mokalled MH; Montgomery RL; Olson EN
J Biol Chem; 2010 May; 285(19):14663-70. PubMed ID: 20190228
[TBL] [Abstract][Full Text] [Related]
8. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.
Matsushita H; Scaglioni PP; Bhaumik M; Rego EM; Cai LF; Majid SM; Miyachi H; Kakizuka A; Miller WH; Pandolfi PP
J Exp Med; 2006 Apr; 203(4):821-8. PubMed ID: 16549595
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice.
Dovey OM; Foster CT; Conte N; Edwards SA; Edwards JM; Singh R; Vassiliou G; Bradley A; Cowley SM
Blood; 2013 Feb; 121(8):1335-44. PubMed ID: 23287868
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.
Chen S; Yao X; Li Y; Saifudeen Z; Bachvarov D; El-Dahr SS
Development; 2015 Mar; 142(6):1180-92. PubMed ID: 25758227
[TBL] [Abstract][Full Text] [Related]
11. HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation.
Turgeon N; Blais M; Gagné JM; Tardif V; Boudreau F; Perreault N; Asselin C
PLoS One; 2013; 8(9):e73785. PubMed ID: 24040068
[TBL] [Abstract][Full Text] [Related]
12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
13. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
14. HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.
Stojanovic N; Hassan Z; Wirth M; Wenzel P; Beyer M; Schäfer C; Brand P; Kroemer A; Stauber RH; Schmid RM; Arlt A; Sellmer A; Mahboobi S; Rad R; Reichert M; Saur D; Krämer OH; Schneider G
Oncogene; 2017 Mar; 36(13):1804-1815. PubMed ID: 27721407
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
Pinkerneil M; Hoffmann MJ; Deenen R; Köhrer K; Arent T; Schulz WA; Niegisch G
Mol Cancer Ther; 2016 Feb; 15(2):299-312. PubMed ID: 26772204
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
17. Karyotypically abnormal human ESCs are sensitive to HDAC inhibitors and show altered regulation of genes linked to cancers and neurological diseases.
Lund RJ; Emani MR; Barbaric I; Kivinen V; Jones M; Baker D; Gokhale P; Nykter M; Lahesmaa R; Andrews PW
Stem Cell Res; 2013 Nov; 11(3):1022-36. PubMed ID: 23941963
[TBL] [Abstract][Full Text] [Related]
18. Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis.
Jurkin J; Zupkovitz G; Lagger S; Grausenburger R; Hagelkruys A; Kenner L; Seiser C
Cell Cycle; 2011 Feb; 10(3):406-12. PubMed ID: 21270520
[TBL] [Abstract][Full Text] [Related]
19. HDAC1/2 Control Proliferation and Survival in Adult Epidermis and Pre‒Basal Cell Carcinoma through p16 and p53.
Zhu X; Leboeuf M; Liu F; Grachtchouk M; Seykora JT; Morrisey EE; Dlugosz AA; Millar SE
J Invest Dermatol; 2022 Jan; 142(1):77-87.e10. PubMed ID: 34284046
[TBL] [Abstract][Full Text] [Related]
20. Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.
Frumm SM; Fan ZP; Ross KN; Duvall JR; Gupta S; VerPlank L; Suh BC; Holson E; Wagner FF; Smith WB; Paranal RM; Bassil CF; Qi J; Roti G; Kung AL; Bradner JE; Tolliday N; Stegmaier K
Chem Biol; 2013 May; 20(5):713-25. PubMed ID: 23706636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
